Westminster Homecare has been acquired by Care at Home
October 2020 — The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.
Westminster Homecare is a specialist provider of care services to the elderly and young adults. It operates a network of branches throughout London and the South of England delivering care services to over 3,500 service users, enabling them to remain independent in their homes for longer.
Care at Home is a privately owned, independent family business providing a range of care services to clients in their own homes, under several brands including Care at Home Services, Beech Tree Total Care, Domus Live-In Care, and now Westminster Homecare. Care at Home partnered with ThinCats, an alternative lender that provides loans to mid-sized UK businesses, to help fund the transaction.
Our role in the transaction
Oaklins Evelyn Partners, based in the UK, worked with the shareholders of Westminster Homecare to deliver a successful sale to a strategic partner. Combined, the group will be one of the largest providers of homecare services, with over 3,700 staff operating from 28 branches delivering homecare to the community and also care in 18 extra care facilities.
Sushil Radia
CEO, Westminster Homecare Ltd.
Talk to the deal team
Related deals
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreSynergia and Bolster have secured acquisition financing for Life & Mobility
Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.
Learn more